| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in PTCT over the last quarter tilts toward selling: insiders offloaded a net 112,078 shares worth roughly $7.8M. In the past 30 days, 0 insiders bought and 2 sold.
Both insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.29M | $89.56M | -5,000 | |
| CEO | 383.9K | $26.62M | - | |
| VP | 105.3K | $7.30M | -627 | |
| CFO | 84.0K | $5.82M | - | |
| VP | 79.1K | $5.49M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 22, 2024 | Jerome B Zeldis45 | Director | Sale+OE10b5-1 | 20,000 | $38.24 | $764,800.00 | -58.0% | -11.0% | +17.8% | |
| May 7, 2024 | Lee Scott Golden | EVP & Chief Medical Officer | Sell10b5-1 | 175 | $32.82 | $5,743.50 | -0.3% | -2.5% | +28.2% | |
| Apr 19, 2024 | Matthew B. Klein53 | Chief Executive Officer | Sell10b5-1 | 3,361 | $24.89 | $83,668.73 | -1.5% | +29.6% | +90.3% | |
| Apr 17, 2024 | Matthew B. Klein53 | Chief Executive Officer | Sell10b5-1 | 1,307 | $25.13 | $32,851.45 | -0.6% | +35.8% | +88.4% | |
| Apr 17, 2024 | Eric Pauwels61 | Chief Executive Officer | Sell | 787 | $25.14 | $19,781.25 | -1.1% | +35.8% | +88.4% | |
| Apr 2, 2024 | Lee Scott Golden | EVP & Chief Medical Officer | Sell | 526 | $28.37 | $14,922.62 | -0.9% | +9.8% | +70.3% | |
| Jan 30, 2024 | Christine Marie Utter58 | SVP, Chief Accounting Officer | Sell10b5-1 | 318 | $27.25 | $8,665.75 | -0.9% | +21.0% | +70.3% | |
| Jan 30, 2024 | Eric Pauwels61 | Chief Business Officer | Sell10b5-1 | 366 | $27.25 | $9,973.79 | -0.8% | +21.0% | +70.3% | |
| Jan 30, 2024 | Mark Elliott Boulding56 | Executive VP and CLO | Sell10b5-1 | 794 | $27.25 | $21,637.14 | -1.1% | +21.0% | +70.3% | |
| Jan 30, 2024 | Neil Gregory Almstead55 | Chief Technical Ops Officer | Sell10b5-1 | 646 | $27.25 | $17,604.02 | -14.8% | +21.0% | +70.3% |